Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management

Chimeric antigen receptor T-cells (CAR-T) are improving outcomes in pediatric and adult patients with relapsed or refractory B-cell acute lymphoblastic leukemias and subtypes of non-Hodgkin Lymphoma. As this treatment is being increasingly utilized, a better understanding of the unique toxicities as...

Full description

Saved in:
Bibliographic Details
Published in:Diseases
Main Authors: Burns, Ethan A., Gentille, Cesar, Trachtenberg, Barry, Pingali, Sai Ravi, Anand, Kartik
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006027/
https://ncbi.nlm.nih.gov/pubmed/33802788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases9010020
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items